| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/16/2006 | EP1689370A2 Method for the production of a solid, orally applicable pharmaceutical composition |
| 08/16/2006 | EP1509241B1 Novel uses of cephaibols |
| 08/16/2006 | EP1387691B1 Blood coagulation factor xiii for treating platelet disorders |
| 08/16/2006 | EP1370641B1 Use of stem cells and cd6-depleted stem cells for inducing tolerance of allogenic transplants and/or for treating leukaemia |
| 08/16/2006 | EP1318991B1 Benzoic acid derivatives and uses thereof |
| 08/16/2006 | EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 08/16/2006 | EP1137410B1 Novel 4-dedimethyl aminotetracycline derivatives |
| 08/16/2006 | EP0314705B2 A novel family of primate hematopoietic growth factors |
| 08/16/2006 | CN1819833A Hgf production accelerator containing heparin-like oligosaccharide |
| 08/16/2006 | CN1819823A Orodispersible pharmaceutical composition of an antithrombotic compound |
| 08/16/2006 | CN1817906A Antibody against human parathormone related peptides |
| 08/16/2006 | CN1817883A New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound |
| 08/16/2006 | CN1817854A Amino acids with affinity for the alpha-2-delta protein |
| 08/16/2006 | CN1817365A Injecting Mailuoning, its preparation and quality control thereof |
| 08/16/2006 | CN1269955C Manufacture of hemoglobin-based oxygen carrier |
| 08/16/2006 | CN1269838C Signal sequences for the production of Leu-hirudine via secretion by E. coli in a culture medium |
| 08/16/2006 | CN1269820C Novel pyrrole derivatives as pharmaceutical agents |
| 08/16/2006 | CN1269804C Metalloproteinase inhibitors |
| 08/15/2006 | USRE39239 Methods for treating early morning pathologies |
| 08/15/2006 | US7091343 Compositions useful as inhibitors of protein kinases |
| 08/15/2006 | US7091326 Fusion protein having enhanced in vivo erythropoietin activity |
| 08/15/2006 | US7091234 Thio-oxindole derivatives |
| 08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
| 08/15/2006 | US7091203 Imidazo[1,3,5]triazinones and their use |
| 08/15/2006 | US7091022 Mitogen activated kinase |
| 08/15/2006 | US7090986 identifying compounds such as antibodies that compete with the binding of Saratin to collagen by determining the binding of said Saratin to collagen in the presence or absence of a competitor. |
| 08/15/2006 | US7090861 Sustained release delivery systems for solutes |
| 08/15/2006 | US7090835 Modified colony stimulating factor for treatment of hematopoietic disorder |
| 08/15/2006 | CA2287267C Improved methods for processing activated protein c |
| 08/15/2006 | CA2256309C Amidino protease inhibitors |
| 08/15/2006 | CA2155334C Pulmonary administration of erythropoietin |
| 08/15/2006 | CA2107439C Phospholipid derivatives containing phosphorous, arsenic, antimony or bismuth |
| 08/10/2006 | WO2006084210A2 Hif modulating compounds and methods of use thereof |
| 08/10/2006 | WO2006084031A1 Imines as ion channel modulators |
| 08/10/2006 | WO2006083003A1 Novel benzamidine compound |
| 08/10/2006 | WO2006082974A1 Remedy for ischemic disease |
| 08/10/2006 | WO2006040318A3 Pi3 kinase gamma inhibitors for the treatment of anaemia |
| 08/10/2006 | WO2006034451A3 Crystalline clopidogrel hydrobromide and processes for preparation thereof |
| 08/10/2006 | US20060178518 3'-[(2z)-[1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hy-drazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 08/10/2006 | US20060178419 3-Sulfonylamino-pyrrolindine -2- one derivatives as inhibitors of factor xa |
| 08/10/2006 | US20060178375 2-(1-Cyclopentylpiperidin-4-yloxy)-5-(4-cyanophenyl)pyrimidine, for example; exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful for the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep disorders |
| 08/10/2006 | US20060178365 Optionally oxidized 6-(2-(5-methylthio-2-pyrimidinyloxy)ethoxy)-2-phenylpyrimidin-4-yl-substituted sulfamides |
| 08/10/2006 | US20060178336 Oral administration of therapeutic agent coupled to transporting agent induces tolerance |
| 08/10/2006 | US20060178317 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060178316 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060178315 For therapy of immune or autoimmune diseases |
| 08/10/2006 | US20060177443 Integrin antagonists |
| 08/10/2006 | US20060177432 Methods and reagents for protease inhibition |
| 08/10/2006 | DE60115222T2 Kombination von defibrotid und g-csf und ihre verwendung zur aktivierung hämatopoietischer vorläuferzellen Progenitor cell combination of defibrotide and g-csf and their use for the activation of hematopoietic |
| 08/10/2006 | DE102005005446A1 Bruchfeste Darreichungsformen mit retardierter Freisetzung Unbreakable dosage forms with delayed release |
| 08/10/2006 | CA2594505A1 Imines as ion channel modulators |
| 08/09/2006 | EP1688495A1 MU-1 member of the cytokine receptor family |
| 08/09/2006 | EP1688488A1 Bispecific antibody substituting for functional proteins |
| 08/09/2006 | EP1688430A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2006 | EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |
| 08/09/2006 | EP1687020A1 Therapeutic use of factor xi |
| 08/09/2006 | EP1686979A2 Activation of hypoxia-inducible gene expression |
| 08/09/2006 | EP1686951A1 Combined cosmetic or therapeutic preparation |
| 08/09/2006 | EP1453949B1 Production of cell suspensions |
| 08/09/2006 | EP1453832B1 Ring fused pyrazole derivatives |
| 08/09/2006 | EP1423429B1 Antibodies against caspase-8, their preparation and use |
| 08/09/2006 | EP1397361B1 Carboline derivatives as pdev inhibitors |
| 08/09/2006 | EP1354032B1 Gene regulation therapy involving ferritin |
| 08/09/2006 | EP1317453B1 Isoxazoles and their use as inhibitors of erk |
| 08/09/2006 | EP1300411B1 Novel disaccharides with anti-arthritic action |
| 08/09/2006 | EP1267954B1 Medical devices suitable for gene therapy regimens |
| 08/09/2006 | EP1263423B1 Composition for the prevention and/or treatment of vascular diseases, consisting of propionyl l-carnitine and coenzyme q10 |
| 08/09/2006 | EP1246623B1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof |
| 08/09/2006 | EP1187613B1 Amide substituted imidazoquinolines |
| 08/09/2006 | EP1032393B1 Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 08/09/2006 | EP0988316B1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 08/09/2006 | CN1816625A Dna-based aptamers for human cathepsin g |
| 08/09/2006 | CN1816353A Medicinal composition for preventing or treating Th1 type immunological disease |
| 08/09/2006 | CN1816345A Preventive and/or remedy for diseases accompanied by tissue destruction |
| 08/09/2006 | CN1816333A Staurosporine derivatives for hypereosinophilic syndrome |
| 08/09/2006 | CN1816327A Use of hif alpha stabilizers for enhancing erythropoiesis |
| 08/09/2006 | CN1814625A Method for preparing calcium chitosan and itsuse for wound hemostasis |
| 08/09/2006 | CN1814284A Method for raising utilizing degree to oral organism-absorbing of lumbrukinase |
| 08/09/2006 | CN1814278A Iirudo-seu-whitmania essence inhalant and preparing method |
| 08/09/2006 | CN1814274A Health-care product for treating cardiovascular and cerebralvascular disease |
| 08/09/2006 | CN1814267A External-use preparation of Chinese medicine for treating ascites |
| 08/09/2006 | CN1814250A Chinese medicine composition for treating liver cirrhosis ascites and use thereof |
| 08/09/2006 | CN1814240A Chinese medicine formula for treating liver cirrhosis ascites |
| 08/09/2006 | CN1814196A Chinese medicine composition for treating functional metrorrhagia and use thereof |
| 08/09/2006 | CN1814193A Chinese meidine composition for treating nephritis dropsy and use thereof |
| 08/09/2006 | CN1814163A Chinese medicine for treating cardiovascular and cerebrovascular trrombus and preparing method |
| 08/09/2006 | CN1814125A Rehmannia-root preparation |
| 08/09/2006 | CN1814119A Yougui capsule |
| 08/09/2006 | CN1814093A Chinese medicine preparation for activating blood-circulation and diminishing congestion, and preparing method |
| 08/09/2006 | CN1814048A Chinese medicine liquid capsule of Folium callicarpae Nudiflorae, preparing method and quality control method |
| 08/09/2006 | CN1814042A Yanyou Chinese medicine preparation and preparing method |
| 08/09/2006 | CN1814023A Blood-supplementing Chinese medicine preparation and preparing method |
| 08/09/2006 | CN1814022A Chinese medicine preparation for tonifying yin and supplementing blood, and preparing method |
| 08/09/2006 | CN1813924A Eight-ingredient amur barberry bark capsule |
| 08/09/2006 | CN1813888A Process for preparing fresh motherwort powder |
| 08/09/2006 | CN1813887A Process for preparing fresh motherwort formulation |
| 08/09/2006 | CN1813884A Use of delphinium glabra plant for preparing drug for stopping pain, hemostasis and anticancer |
| 08/09/2006 | CN1813867A Astragalus mongholicus tablet, and its preparation and active constituent content measuring method |
| 08/09/2006 | CN1813836A Medicinal composition for treating cardio-cerebrovascular disease |
| 08/09/2006 | CN1813829A Injection holly root lyophilized powder for treating cardio-cerebral vascular disease and its preparing method |